NCT00023621View on ClinicalTrials.gov

Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 28, 2001

Study Completion Date

July 31, 2007

Conditions
Non-melanomatous Skin Cancer
Interventions
DRUG

celecoxib

Trial Locations (2)

10032

Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, New York

94115

UCSF Comprehensive Cancer Center, San Francisco

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of California, San Francisco

OTHER

NCT00023621 - Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome | Biotech Hunter | Biotech Hunter